AAAAAA

   
Results: 1-12 |
Results: 12
Prevalence of iodine- and thyroglobulin-negative findings in differentiated thyroid cancer - A retrospective analysis of patients treated from 1961 to 1998 in a university hospital
Authors: Klutmann, S Jenicke, L Geiss-Tonshoff, M Bohuslavizki, KH Mester, J Clausen, M
Citation: S. Klutmann et al., Prevalence of iodine- and thyroglobulin-negative findings in differentiated thyroid cancer - A retrospective analysis of patients treated from 1961 to 1998 in a university hospital, NUKLEARMED, 40(5), 2001, pp. 143-147
Lymph scintigraphy and pre- and intraoperative gamma probe measurements for localization of sentinel lymph nodes (SLN) in breast cancer
Authors: Brenner, W Ostertag, H Czech, N zum Felde, U Kampen, WU Klutmann, S Bohuslavizki, KH Luttges, J Sprenger, A Henze, E
Citation: W. Brenner et al., Lymph scintigraphy and pre- and intraoperative gamma probe measurements for localization of sentinel lymph nodes (SLN) in breast cancer, NUKLEARMED, 39(3), 2000, pp. 82-87
FDG PET detection of unknown primary tumors
Authors: Bohuslavizki, KH Klutmann, S Kroger, S Sonnemann, U Buchert, R Werner, JA Mester, J Clausen, M
Citation: Kh. Bohuslavizki et al., FDG PET detection of unknown primary tumors, J NUCL MED, 41(5), 2000, pp. 816-822
Effect of radiosynovectomy in patients with inflammatory joint disorders not caused by rheumatoid arthritis
Authors: Kroger, S Sawula, JA Klutmann, S Brenner, W Bohuslavizki, KH Henze, E Clausen, M
Citation: S. Kroger et al., Effect of radiosynovectomy in patients with inflammatory joint disorders not caused by rheumatoid arthritis, NUKLEARMED, 38(7), 1999, pp. 279-284
Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioicacid (amifostine) in high-dose radioiodine treatment: Results obtained in a rabbit animal model and in a double-blind multi-arm trial
Authors: Bohuslavizki, KH Klutmann, S Jenicke, L Kroger, S Buchert, R Mester, J Clausen, M
Citation: Kh. Bohuslavizki et al., Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioicacid (amifostine) in high-dose radioiodine treatment: Results obtained in a rabbit animal model and in a double-blind multi-arm trial, CANC BIO R, 14(5), 1999, pp. 337-347
F-18-FDG for detecting occult primary tumors in patients with lymph node metastases in the neck.
Authors: Bohuslavizki, KH Klutmann, S Sonnemann, U Thoms, J Kroger, S Werner, JA Mester, J Clausen, M
Citation: Kh. Bohuslavizki et al., F-18-FDG for detecting occult primary tumors in patients with lymph node metastases in the neck., LARY RH OTO, 78(8), 1999, pp. 445-449
Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model
Authors: Bohuslavizki, KH Klutmann, S Jenicke, L Brenner, W Feyerabend, B Henze, E Clausen, M
Citation: Kh. Bohuslavizki et al., Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model, INT J RAD O, 45(1), 1999, pp. 181-186
Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment - Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer
Authors: Bohuslavizki, KH Klutmann, S Brenner, W Kroger, S Buchert, R Bleckmann, C Mester, J Henze, E Clausen, M
Citation: Kh. Bohuslavizki et al., Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment - Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer, STRAH ONKOL, 175, 1999, pp. 6-12
Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer
Authors: Bohuslavizki, KH Klutmann, S Bleckmann, C Brenner, W Lassmann, S Mester, J Henze, E Clausen, M
Citation: Kh. Bohuslavizki et al., Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer, STRAH ONKOL, 175(2), 1999, pp. 57-61
Clinical value of 24-hour delayed imaging in somatostatin receptor scintigraphy for meningioma
Authors: Klutmann, S Bohuslavizki, KH Tietje, N Kroger, S Behnke, A Brenner, W Mester, J Henze, E Clausen, M
Citation: S. Klutmann et al., Clinical value of 24-hour delayed imaging in somatostatin receptor scintigraphy for meningioma, J NUCL MED, 40(8), 1999, pp. 1246-1251
Lymphoscintigraphy in tumors of the head and neck using double tracer technique
Authors: Klutmann, S Bohuslavizki, KH Brenner, W Hoft, S Kroger, S Werner, JA Henze, E Clausen, M
Citation: S. Klutmann et al., Lymphoscintigraphy in tumors of the head and neck using double tracer technique, J NUCL MED, 40(5), 1999, pp. 776-782
Effect of attenuation correction on lesion detectability in FDG PET of breast cancer
Authors: Bleckmann, C Dose, J Bohuslavizki, KH Buchert, R Klutmann, S Mester, J Janicke, F Clausen, M
Citation: C. Bleckmann et al., Effect of attenuation correction on lesion detectability in FDG PET of breast cancer, J NUCL MED, 40(12), 1999, pp. 2021-2024
Risultati: 1-12 |